These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8732703

  • 1. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N, Stephenson JM, Fuller JH.
    Diabetes Care; 1996 May; 19(5):423-30. PubMed ID: 8732703
    [Abstract] [Full Text] [Related]

  • 2. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N, Stephenson JM, Fuller JH.
    Diabetes Care; 1995 Jun; 18(6):785-92. PubMed ID: 7555504
    [Abstract] [Full Text] [Related]

  • 3. Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
    Mattock MB, Cronin N, Cavallo-Perin P, Idzior-Walus B, Penno G, Bandinelli S, Standl E, Kofinis A, Fuller JH, EURODIAB IDDM Complications Study.
    Diabet Med; 2001 Jan; 18(1):59-67. PubMed ID: 11168343
    [Abstract] [Full Text] [Related]

  • 4. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
    Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group.
    Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B.
    Diabetes Care; 1996 Jul; 19(7):689-97. PubMed ID: 8799621
    [Abstract] [Full Text] [Related]

  • 6. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Greaves M, Malia RG, Goodfellow K, Mattock M, Stevens LK, Stephenson JM, Fuller JH.
    Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
    [Abstract] [Full Text] [Related]

  • 7. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
    Davies L, Fulcher GR, Atkins A, Frumar K, Monaghan J, Stokes G, Clifton-Bligh P, McElduff A, Robinson B, Stiel J, Twigg S, Wilmshurst E.
    J Diabetes Complications; 1999 Jun; 13(1):45-51. PubMed ID: 10232709
    [Abstract] [Full Text] [Related]

  • 8. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [Abstract] [Full Text] [Related]

  • 10. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [Abstract] [Full Text] [Related]

  • 11. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study.
    Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, Kerényi Z, Tamás G, Ward JD, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabet Med; 2002 Nov; 19(11):900-9. PubMed ID: 12421426
    [Abstract] [Full Text] [Related]

  • 12. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
    Engelen L, Schalkwijk CG, Eussen SJ, Scheijen JL, Soedamah-Muthu SS, Chaturvedi N, Fuller JH, Stehouwer CD.
    Cardiovasc Diabetol; 2015 May 30; 14():67. PubMed ID: 26025465
    [Abstract] [Full Text] [Related]

  • 13. A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study.
    Lloyd CE, Stephenson J, Fuller JH, Orchard TJ.
    Diabetes Care; 1996 Mar 30; 19(3):219-25. PubMed ID: 8742565
    [Abstract] [Full Text] [Related]

  • 14. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
    Levitt NS, Adams G, Salmon J, Marks IN, Musson G, Swanepoel C, Levy M, Byrne MJ.
    Diabetes Care; 1995 Jul 30; 18(7):971-4. PubMed ID: 7555558
    [Abstract] [Full Text] [Related]

  • 15. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
    Savage S, Estacio RO, Jeffers B, Schrier RW.
    Diabetes Care; 1996 Nov 30; 19(11):1243-8. PubMed ID: 8908388
    [Abstract] [Full Text] [Related]

  • 16. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group.
    Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC.
    Diabetologia; 1999 Jan 30; 42(1):68-75. PubMed ID: 10027581
    [Abstract] [Full Text] [Related]

  • 17. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP.
    Diabetes Care; 1998 May 30; 21(5):841-8. PubMed ID: 9589252
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
    Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller JH, EURODIAB Prospective Complications Study Group.
    Diabetes Care; 2004 Feb 30; 27(2):530-7. PubMed ID: 14747240
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of micro- and macroalbuminuria in a Canarian population of type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control.
    De Pablos PL, Martinez J, Martinez MP, Doreste JA.
    Diabetes Metab; 1998 Sep 30; 24(4):337-43. PubMed ID: 9805644
    [Abstract] [Full Text] [Related]

  • 20. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
    Sjølie AK, Stephenson J, Aldington S, Kohner E, Janka H, Stevens L, Fuller J.
    Ophthalmology; 1997 Feb 30; 104(2):252-60. PubMed ID: 9052629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.